Pediatrix Medical Group (NYSE:MD) Hits New 12-Month Low at $13.66

Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $13.66 and last traded at $14.00, with a volume of 151025 shares traded. The stock had previously closed at $14.00.

Wall Street Analyst Weigh In

MD has been the subject of several analyst reports. StockNews.com initiated coverage on Pediatrix Medical Group in a research report on Thursday. They set a “hold” rating for the company. Credit Suisse Group decreased their target price on Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating for the company in a research report on Wednesday, February 22nd. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $19.00.

Pediatrix Medical Group Price Performance

The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 0.71. The firm has a market cap of $1.19 billion, a P/E ratio of 17.89, a PEG ratio of 2.22 and a beta of 1.75. The company has a fifty day moving average price of $15.36 and a two-hundred day moving average price of $16.13.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors have recently modified their holdings of MD. Norges Bank bought a new stake in Pediatrix Medical Group in the 4th quarter valued at approximately $11,064,000. Lazard Asset Management LLC lifted its stake in Pediatrix Medical Group by 24.3% in the 1st quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock valued at $76,631,000 after acquiring an additional 637,798 shares in the last quarter. ArrowMark Colorado Holdings LLC lifted its stake in Pediatrix Medical Group by 11.2% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 4,048,957 shares of the company’s stock valued at $60,168,000 after acquiring an additional 407,239 shares in the last quarter. Marshall Wace LLP bought a new stake in Pediatrix Medical Group in the 3rd quarter valued at approximately $4,010,000. Finally, Vanguard Group Inc. lifted its stake in Pediatrix Medical Group by 2.3% in the 1st quarter. Vanguard Group Inc. now owns 9,541,964 shares of the company’s stock valued at $224,045,000 after acquiring an additional 212,150 shares in the last quarter. Institutional investors own 95.99% of the company’s stock.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.